Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
Why Dexcom — And The Obesity Market — Could Benefit From This New FDA Win
March 06, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
ABT
DXCM
LLY
NVO
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription
March 06, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
DXCM
Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates
March 06, 2024
Via
Newsfile
Topics
Economy
Exposures
Product Safety
Supply Chain
Tickers
ADAP
Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant
March 06, 2024
Via
MarketBeat
Exposures
Product Safety
Tickers
LLY
NVO
VANI
VKTX
The UAE Is Exploring the Rollout of Psychedelic Assisted Therapies
March 06, 2024
Via
Newsworthy
Exposures
Product Safety
"Overdosing" America's Youth: The Dangerous Trend in Antidepressant Prescribing
March 04, 2024
Via
PRLog
Topics
Death
Exposures
Death
Product Safety
Rio Rancho Dentist Treats Obstructive Sleep Apnea, Snoring, with Oral Appliance Therapy
March 02, 2024
Via
PRLog
Exposures
Product Safety
Freezies Treats Expands Reach with Plans for Physical Storefront and International Growth, Spreads Sweetness Amidst Global Challenges
March 05, 2024
Via
Get News
Topics
Product Recall
Exposures
COVID-19
Legal
Product Safety
Elon Musk's First Neuralink Patient Made A Full Recovery, But The FDA And Some Doctors Have Concerns About Patient's Long-Term Health
March 05, 2024
Via
Benzinga
Exposures
Product Safety
Choosing the right weight management medication to best suit your health goals
March 05, 2024
Via
Brandpoint
Exposures
Product Safety
Trial Endpoint Reached for First Suicidal Bipolar Depression, Chronic Pain and PTSD Drug; Agreement with Partners Can Provide up to $329 Million and Royalties: NRx Pharmaceuticals (Nasdaq: NRXP)
March 04, 2024
Via
Get News
Exposures
Product Safety
Tickers
NRXP
REMSleep Holdings Shareholder Update
March 04, 2024
Via
NewMediaWire
Exposures
Product Safety
Tickers
RMSL
REMSleep Holdings Shareholder Update
March 04, 2024
Via
TheNewswire.com
Exposures
Product Safety
Tickers
RMSL
BioMedNewsBreaks – BioVie Inc. (NASDAQ: BIVI) to Secure ~$21M in Public Offering
March 04, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
BIVI
What's Going On With BridgeBio Pharma Stock On Monday?
March 04, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BAYRY
BAYZF
BBIO
Your Weed Posts On Social Media Could Change Federal Law, Seriously
March 04, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Product Safety
ROSEN, NATIONAL TRIAL COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 03, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, NATIONAL TRIAL COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 03, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 02, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 02, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 01, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INMD
March 01, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
INMD
Real Estate Expert Iris Ramos Shares Insights and Success Stories on the Agents Lounge Podcast
March 01, 2024
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
Women's History Month: Pharmacy Chains CVS Health, Walgreens To Start Dispensing Abortion Pill Mifepristone In Select States
March 01, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
CVS
WBA
Intelligent Bio Solutions Inc (NASDAQ: INBS) Teams Up with Cliantha Research for FDA 510(k) Pathway Clinical Study
March 01, 2024
Via
AB Newswire
Exposures
Product Safety
Tickers
INBS
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Commence HYPER-H23-1 Clinical Trial
March 01, 2024
Via
CannabisNewsWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
LEXX
LEXXW
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Commence HYPER-H23-1 Clinical Trial
March 01, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
LEXX
Real Estate Expert Iris Ramos Shares Insights and Success Stories on the Agents Lounge Podcast
March 01, 2024
Via
Authority Press Wire
Topics
Product Recall
Exposures
Legal
Product Safety
IRHYTHM (IRTC) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies iRhythm Investors of a Class Action Lawsuit and Upcoming Deadline
March 01, 2024
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
IRTC
IRHYTHM (IRTC) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies iRhythm Investors of a Class Action Lawsuit and Upcoming Deadline
March 01, 2024
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
IRTC
< Previous
1
2
...
26
27
28
29
30
31
32
33
34
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.